Invex Therapeutics Ltd (ASX:IXC)
Australia · Delayed Price · Currency is AUD 0.0920
+0.0070 (8.24%)
Aug 1, 2025, 10:28 AM AEST
ATSG Market Cap
Invex Therapeutics has a market cap or net worth of 6.91 million as of August 1, 2025. Its market cap has decreased by -60.85% in one year.
Market Cap
6.91M
Enterprise Value
1.11M
Revenue
1.21M
Ranking
n/a
PE Ratio
60.89
Stock Price
$0.09
Market Cap Chart
Since July 5, 2019, Invex Therapeutics's market cap has decreased from 59.13M to 6.91M, a decrease of -88.31%. That is a compound annual growth rate of -29.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 6.91M | 39.39% |
| Dec 23, 2024 | 4.96M | -18.52% |
| Dec 27, 2023 | 6.09M | -85.14% |
| Dec 28, 2022 | 40.96M | -22.70% |
| Dec 31, 2021 | 52.98M | -1.40% |
| Dec 31, 2020 | 53.74M | 13.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 131.27B |
| Pro Medicus | 33.40B |
| Cochlear | 20.72B |
| Sonic Healthcare | 13.93B |
| Ramsay Health Care | 8.94B |
| Telix Pharmaceuticals | 7.00B |
| Ansell | 4.38B |
| Mesoblast | 3.13B |